Skip to the page

Data / Drug companies / Aveva Drug Delivery Systems Inc.

Aveva Drug Delivery Systems Inc.: 23 products in the FDA NDC directory, labeler code 3215

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Aveva Drug Delivery Systems Inc. (labeler code 3215) lists 23 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 17 prescription drugs, 6 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 24, 2025.

The request: Watch Aveva Drug Delivery Systems Inc. (FDA labeler code 3215): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
3215
Products in commercial distribution
23
Packages
28
Finished drugs by generic name
4
Prescription products
17
Over the counter products
6
Controlled substance products
Schedule II 8, Schedule III 9
Flagged as original packager
23 of 23 products that carry the flag
Started marketing in the last 12 months
3
Earliest marketing start
August 29, 2023
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)23100%

Products by type

TypeProductsShare
Prescription drugs1773.9%
Over the counter drugs626.1%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Patch, extended release1356.5%
Patch626.1%
Film417.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Nicotine Transdermal System3215-0122PatchGeneric drugs (ANDA)November 24, 2025
Nicotine Transdermal System3215-0121PatchGeneric drugs (ANDA)November 24, 2025
Nicotine Transdermal System3215-0120PatchGeneric drugs (ANDA)November 24, 2025
Buprenorphine and Naloxone3215-6522FilmGeneric drugs (ANDA)March 7, 2025
Buprenorphine and Naloxone3215-6521FilmGeneric drugs (ANDA)March 7, 2025
Fentanyl3215-7707Patch, extended releaseGeneric drugs (ANDA)February 11, 2025
Fentanyl3215-7705Patch, extended releaseGeneric drugs (ANDA)February 10, 2025
Fentanyl3215-7703Patch, extended releaseGeneric drugs (ANDA)February 5, 2025
Fentanyl3215-7701Patch, extended releaseGeneric drugs (ANDA)January 30, 2025
Fentanyl3215-7702Patch, extended releaseGeneric drugs (ANDA)January 22, 2025
Fentanyl3215-7708Patch, extended releaseGeneric drugs (ANDA)January 6, 2025
Fentanyl3215-7706Patch, extended releaseGeneric drugs (ANDA)January 6, 2025
Fentanyl3215-7704Patch, extended releaseGeneric drugs (ANDA)January 6, 2025
Nicotine Transdermal System3215-1203PatchGeneric drugs (ANDA)June 25, 2024
Nicotine Transdermal System3215-1202PatchGeneric drugs (ANDA)June 25, 2024
Nicotine Transdermal System3215-1201PatchGeneric drugs (ANDA)June 25, 2024
Buprenorphine3215-1525Patch, extended releaseGeneric drugs (ANDA)November 1, 2023
Buprenorphine3215-1524Patch, extended releaseGeneric drugs (ANDA)November 1, 2023
Buprenorphine3215-1523Patch, extended releaseGeneric drugs (ANDA)November 1, 2023
Buprenorphine3215-1522Patch, extended releaseGeneric drugs (ANDA)November 1, 2023
Buprenorphine3215-1521Patch, extended releaseGeneric drugs (ANDA)November 1, 2023
Buprenorphine and Naloxone3215-6524FilmGeneric drugs (ANDA)August 29, 2023
Buprenorphine and Naloxone3215-6523FilmGeneric drugs (ANDA)August 29, 2023

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.